Antiplatelet therapy for aneurysmal subarachnoid haemorrhage

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Dorhout Mees, S M ^b   Van Den Bergh, W M ^b   Algra, A ^b   Rinkel, Gabriel J E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Brain ischemia *prevention control ; Intracranial aneurysm *complications; therapy ; Platelet aggregation inhibitors *therapeutic use ; Randomized controlled trials as topic

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; TICLOPIDINE;

ANEURYSM; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 44949086642     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006184.pub2     Document Type: Review

References (37)

1. Hop 2000 {published data only} Hop JW, Rinkel GJE, Algra A, Berkelbach van der Sprenkel JW, van Gijn J. Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology 2000;54:872-8.
2. Mendelow 1982 {published data only} Mendelow AD, Stockdill G, Steers AJW, Hayes J, Gillingham FJ. Double-blind trial of aspirin in patients receiving tranexamic acid for subarachnoid haemorrhage. Acta Neurochirurgica 1982;62:195-202.
3. Ono 1984 {published data only} Ono H, Mizukami M, Kitamura K, Kikuchi H. Subarachnoid hemorrhage. Agents and Actions Supplements 1984;15:259-72.
4. Shaw 1985 {published data only} Shaw MDM, Foy PM, Conway M, Pickard JD, Maloney P, Spillane JA, et al.Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 1985;63:699-703.
5. Suzuki 1989 {published data only} Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, et al.Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study. Neurological Research 1989;11:79- 88.
6. Tokiyoshi 1991 {published data only} Tokiyoshi K, Ohnishi T, Nii Y. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surgical Neurology 1991;36:112-8.
7. van den Bergh 2006 {published data only} van den Bergh WM, Algra A, Dorhout Mees SM, van Kooten F, Dirven CM, van Gijn J, et al.Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke 2006;37:2326-30.
8. Fujita 1990 Fujita K, Shirakuni T, Ehara K, Tamaki N, Matsumoto S. Prevention of the symptomatic vasospasm (SV) by antiplatelet agent (ticlopidine) and prophylactic hypervolemic hemodilution therapy - evaluated by transcranial doppler sonography (TCD). Stroke 1990;21 Suppl I:1-68.
9. Hirashima 2001 Hirashima Y, Endo S, Nukui H, Kobayashi N, Takaku A. Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasmafter aneurysmal subarachnoid hemorrhage - open clinical trial to investigate efficacy and safety. Neurologia medico-chirurgica 2001;41(4):165-76.
10. Mizukami 1981 *Mizukami M, Kikuchi H, Ono H, Taneda M. Randomized study of ticlopidine on cerebral vasospasm following ruptured aneurysm. Thrombosis and Haemostasis 1981;46:307.
11. Niemi 1999 Niemi T, Tanskanen P, Taxell C, Juvela S, Randell T, Rosenberg P. Effects of nonsteroidal anti-inflammatory drugs on hemostasis in patients with aneurysmal subarachnoid hemorrhage. Journal of Neurosurgical Anesthesiology 1999;11(3):188-94.
12. Suzuki 1981 Suzuki S, Sobata E, Iwabuchi T. Prevention of cerebral ischemic symptoms in cerebral vasospasm with trapidil, an antagonist and selective synthesis inhibitor of thromboxane A2. Neurosurgery 1981;9:679-85.
13. Suzuki 1985 Suzuki S, Iwabuchi T, Tanaka T, Kanayama S, Ottomo M, Hatanaka M, et al.Prevention of cerebral vasospasm with OKY-046, an imidazole derivative and a thromboxane synthetase inhibitor: a preliminary co-operative clinical study. Acta Neurochirurgica 1985;77:133-41.
14. Tani 1984 Tani E, Maeda Y, Fukumori T, Nakano M, Kochi N, Morimura T, et al.Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery. Journal of Neurosurgery 1984;61:24-9.
15. Yano 1993 Yano K, Kuroda T, Tanabe Y, Yamada H. Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy. Acta Neurochirurgica 1993;125:15-9.
16. ACROSS 2000 [No authors listed]. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 2000;31:1843-50.
17. Brilstra 2000 Brilstra EH, Rinkel GJE, Algra A, van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology 2000;55:1656-60.
18. Cosmi 2001 Cosmi B, Rubboli A, Castelvetri C, Milandri M. Ticlopidine versus oral anticoagulation for coronary stenting. Cochrane Database of Systematic Reviews 2001, Issue 4.Art. No.: CD002133. DOI:10.1002/14651858.CD002133.
19. de Rooij 2007 de Rooij NK, linn FHH, van der Plas JAP, Algra A, Rinkel GJE. Incidence of subarachnoid hemorrhage: a ten year update of a systematic review with emphasis of role of region, gender, age and time trend. In preparation.
20. Deeks 2001 Deeks JJ, Altman DG, Bradburn MJ. Statisticalmethods for examining heterogeneity and combining results fromseveral studies inmeta-analysis. In: EggerM, Davey SmithG, AltmanDG editor(s). Systematic reviews in health care: meta-analysis in context. 2nd Edition. London: BMJ Publication Group, 2001.
21. Dorsch 1995 Dorsch NW. Cerebral arterial spasm: a clinical review. British Journal of Neurosurgery 1995;9:403-12.
22. Hirashima 2005 Hirashima Y, Hamada H, Kurimoto M, Origasa H, Endo S. Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2005;102:882-7.
23. Honma 1989 Honma Y, Clower BR, Haining JL, Smith RR. Comparison of intimal platelet accumulation in cerebral arteries in two experimental models of subarachnoid hemorrhage. Neurosurgery 1989;24:487-90.
24. Hop 1997 Hop JW, Rinkel GJE, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660-4.
25. Juvela 1991 Juvela S, Hillbom M, Kaste M. Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. Journal of Neurosurgery 1991;74:386-92.
26. Juvela 1995 Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 1995;82:945-52.
27. Okhuma 1991 Okhuma H, Suzuki S, Kimura M, Sobata E. Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1991;22:854-9.
28. Okhuma 1993 Okhuma H, Ogane K, Fujita S, Manabe H, Suzuki S. Impairment of anti-platelet-aggregating activity of endothelial cells after experimental subarachnoid hemorrhage. Stroke 1993;24:1541-6.
29. Patrono 1994 Patrono C. Aspirin as an antiplatelet drug. New England Journal of Medicine 1994;330:1287-94.
30. Rabinstein 2004 Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, et al.Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004;35:1862-6.
31. Rinkel 2005 Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews 2005, Issue 1.
32. Roos 2000 Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. Journal of Neurology, Neurosurgery and Psychiatry 2000;68:337-41.
33. Toussaint 2004 Toussaint LG, Friedman JA, Wijdicks EFM, Piepgras DG, Pichelmann MA, McIver JI, et al. Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2004;101:921-5.
34. van der Schaaf 2002 van der Schaaf IC, Ruigrok YM, Rinkel GJE, Algra A, van Gijn J. Study design and outcome measures in studies on aneurysmal subarachnoid hemorrhage. Stroke 2002;33:2043-6.
35. Vane 2003 Vane JR, Botting RM. The mechanism of action of aspirin. Thrombosis Research 2003;110:255-8.
36. Vinge 1988 Vinge E, Brandt L, Ljunggren B, Andersson KE. Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage. Stroke 1988;19:644-7.
37. Weinberger 2005 Weinberger J. Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke. Drugs 2005;65:461-71.